SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Founded in 1999, EBM stood for “evidence-based medicine” long before evidence- based medicine was in vogue. In collaboration with leading research institutions such as Duke University, Emory University, and Vanderbilt University, the company developed evidence-based clinical guidelines and tools to help hospitals, health plans, patients, and other healthcare stakeholders stay abreast of the best and most cost-effective treatments for hundreds of common diseases and medical conditions.
EBM Solutions was acquired by HealthGate Data Corp. in 2003.
EBM Solutions
Nashville, TN
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.